Kimberlee C. Drapkin
Director · LENZ Therapeutics, Inc.
Individual
- 2025
- Jun 16, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kimberlee C. Drapkin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephen Basil Thomas - $2.25M in CLYM purchases and sales in the last 12 months
- Aoife Brennan - $407K in CLYM purchases and sales in the last 12 months
- Shawn Olsson - $261K in LENZ purchases and sales in the last 12 months
- Evert B. Schimmelpennink - $251K in LENZ purchases and sales in the last 12 months
- James W. McCollum - $239K in LENZ purchases and sales in the last 12 months
- Daniel R. Chevallard - $114K in LENZ purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kimberlee C. Drapkin?
Kimberlee C. Drapkin is a corporate insider, tracked as Director of LENZ Therapeutics, Inc. (LENZ). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kimberlee C. Drapkin last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 4 filings going back to 2025.
